155 related articles for article (PubMed ID: 12662122)
1. Nonsteroidal anti-inflammatory drug use and the risk for Alzheimer's disease: dissecting the epidemiological evidence.
Launer L
Drugs; 2003; 63(8):731-9. PubMed ID: 12662122
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta‑analysis of observational studies to check the protective role of non‑steroidal anti‑inflammatory drugs in Alzheimer's disease.
Asthana A; Tripathi S; Agarwal R
Acta Neurobiol Exp (Wars); 2023 Dec; 83(4):386-394. PubMed ID: 38224283
[TBL] [Abstract][Full Text] [Related]
3. Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
Hsu D; Marshall GA
Curr Alzheimer Res; 2017; 14(4):426-440. PubMed ID: 27697063
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond.
Garmendia JV; De Sanctis CV; Das V; Annadurai N; Hajduch M; De Sanctis JB
Curr Neuropharmacol; 2024; 22(6):1080-1109. PubMed ID: 37898823
[TBL] [Abstract][Full Text] [Related]
5. Acetylsalicylic Acid-Primus Inter Pares in Pharmacology.
Fijałkowski Ł; Skubiszewska M; Grześk G; Koech FK; Nowaczyk A
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500502
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer's Disease.
Philippens IHCHM; Langermans JAM
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33920929
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.
Philippens IH; Ormel PR; Baarends G; Johansson M; Remarque EJ; Doverskog M
J Alzheimers Dis; 2017; 55(1):101-113. PubMed ID: 27662314
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System.
Yagami T; Koma H; Yamamoto Y
Mol Neurobiol; 2016 Sep; 53(7):4754-71. PubMed ID: 26328537
[TBL] [Abstract][Full Text] [Related]
9. The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease.
Lynch MA
Immunology; 2014 Mar; 141(3):292-301. PubMed ID: 23876085
[TBL] [Abstract][Full Text] [Related]
10. Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's Disease.
Bulic B; Ness J; Hahn S; Rennhack A; Jumpertz T; Weggen S
Curr Neuropharmacol; 2011 Dec; 9(4):598-622. PubMed ID: 22798753
[TBL] [Abstract][Full Text] [Related]
11. Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer's disease risk in Chinese.
Tang W; He M; Yang B; Wei K; Yin M; Zhang L
Neurol Sci; 2013 May; 34(5):695-9. PubMed ID: 22622868
[TBL] [Abstract][Full Text] [Related]
12. The role of nitric oxide in prostaglandin biology; update.
Kim SF
Nitric Oxide; 2011 Oct; 25(3):255-64. PubMed ID: 21820072
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs, aspirin, and cognitive function in the Baltimore longitudinal study of aging.
Waldstein SR; Wendell CR; Seliger SL; Ferrucci L; Metter EJ; Zonderman AB
J Am Geriatr Soc; 2010 Jan; 58(1):38-43. PubMed ID: 20122039
[TBL] [Abstract][Full Text] [Related]
14. Does neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon TC; Alto LT; McAlpine FE; Tansey MG
Mol Neurodegener; 2009 Nov; 4():47. PubMed ID: 19917131
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology.
McAlpine FE; Lee JK; Harms AS; Ruhn KA; Blurton-Jones M; Hong J; Das P; Golde TE; LaFerla FM; Oddo S; Blesch A; Tansey MG
Neurobiol Dis; 2009 Apr; 34(1):163-77. PubMed ID: 19320056
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.
Walker D; Lue LF
Curr Neuropharmacol; 2007 Dec; 5(4):232-43. PubMed ID: 19305740
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.
Walker DG; Dalsing-Hernandez JE; Campbell NA; Lue LF
Exp Neurol; 2009 Jan; 215(1):5-19. PubMed ID: 18938162
[TBL] [Abstract][Full Text] [Related]
18. Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia.
Yagami T
Curr Neuropharmacol; 2006 Jan; 4(1):87-100. PubMed ID: 18615138
[TBL] [Abstract][Full Text] [Related]
19. CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.
Zhu Y; Hou H; Nikolic WV; Ehrhart J; Rrapo E; Bickford P; Giunta B; Tan J
PLoS One; 2008 May; 3(5):e2135. PubMed ID: 18478117
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the quality of longitudinal statistical applications in original publications on Alzheimer's disease.
Xiong C; Tang Y; van Belle G; Miller JP; Launer LJ; Morris JC
Neuroepidemiology; 2008; 30(2):112-9. PubMed ID: 18334827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
